[15]
The critical paragraph of the Second Order is paragraph 5. It limits what can be protected as confidential information:
"5. The following information may be designated as
Confidential Information
:
(a) Information regarding the specific formulation of Novopharm's lansoprazole 15 and 30 mg. delayed release capsules, which is the identity of the non-medicinal ingredients, and their form and/or amounts utilized (e.g. 'standard', 'strength' or 'units'); and
(b) Information or data regarding the comparative bioequivalence of Novopharm's lansoprazole 15 and 30 mg. delayed release capsules, but not the conclusions about any such information."
3. EVIDENCE
Mr. David Windross